News

PPD‘s net income was $45.42m, compared to $20.98m for the same period in the prior year. The company has posted operating income of $57.15m for the second quarter

As per the terms of the deal, Astellas is eligible to get an undisclosed upfront payment from Merck along with development, regulatory and sales milestone. Earlier, Cardiome Pharma

The granting of certificate follows a proper inspection conducted by the Belgian authorities in May 2011. With this certification, Ablynx is now eligible to conduct preclinical testing and

Under the agreement, CSL has got the rights for using a cell line for the cGMP production of an undisclosed antibody. The licensed cell line was generated by

Gilead Sciences‘ net income was $746.23m, compared to $712.06m for the same period in the prior year. The company’s income from operations was $1.02bn for the second quarter

Raintree Systems Version 10 is a 2011/2012 compliant and has been certified as a Complete EHR by ONC-ATCB, in accordance with the applicable certification criteria adopted by the

The US Food and Drug Administration has approved eltrombopag under the trade name Promacta as a treatment of chronic ITP who have had an insufficient response to corticosteroids,

In the new plant, the company intends to manufacture PLX (PLacental eXpanded) cell product candidates which is indicated as a treatment for critical limb ischemia (CLI), adjuvant hip

Biogen Idec‘s net income was $304.49m, compared to $294.64m for the same period in the prior year. The company’s income from operations was $410.81m for the second quarter